SIBNAYAL

This brand name is authorized in Austria, Croatia, Estonia, France, Ireland, Italy, Lithuania, Poland, Romania.

Active ingredients

The drug SIBNAYAL contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII EE90ONI6FF - POTASSIUM CITRATE
 

Citrate and citric acid solutions are systematic and urinary alkalinizers thereby providing symptomatic relief of dysuria.

 
Read more about Potassium citrate
2
UNII HM5Z15LEBN - POTASSIUM BICARBONATE
 
Read more about Potassium bicarbonate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
A12BA30 Combinations A Alimentary tract and metabolism → A12 Mineral supplements → A12B Potassium → A12BA Potassium
Discover more medicines within A12BA30

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1847459, 1847460, 1847471, 1847482, 1847493, 1847505, 1847516, 1847527, 1847538, 1847549
FR Base de données publique des médicaments 64876209, 68005178
IT Agenzia del Farmaco 049478011, 049478023, 049478035, 049478047, 049478050, 049478062, 049478074, 049478086, 049478098, 049478100, 049478112, 049478124
LT Valstybinė vaistų kontrolės tarnyba 1092570, 1092571, 1092572, 1092573, 1092574, 1092575, 1092576, 1092577, 1092578, 1092579, 1092580, 1092581
PL Rejestru Produktów Leczniczych 100463308, 100463315
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W69436001, W69436002, W69436003, W69436004, W69436005, W69436006, W69437001, W69437002, W69437003, W69437004, W69437005, W69437006

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.